In recent weeks, Abbott Laboratories raised its quarterly dividend for the 52nd consecutive year and secured CE Mark approval ...

New peer-reviewed research shows Apple Watch detected 4x more AFib cases than standard care, including 57% of people with no ...

Dutch trial establishes feasibility of screening approach in routine specialty care ...

Though the trial demonstrates the feasibility of the approach, future research is needed to assess the clinical impact.

Medtronic won CE mark for the Affera Sphere-360 catheter and completed the first cases of the device in the Horizon 360 IDE ...

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

Abbott Laboratories' second-generation pulse field ablation device for atrial fibrillation has received European CE Mark approval earlier than expected, the North Chicago-based company said today. The ...

The global left atrial appendage closure (LAAC) devices market is projected to register a robust growth from 2025 to 2033.

DEAR DR. ROACH: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...

For patients with Afib, using a wearable device can lead to higher rates of anxiety about their Afib symptoms and treatment, doctor visits, and use of informal healthcare resources, according to a new ...